Glycosylation Pattern of Serum Clusterin in Psoriatic Arthritis and Rheumatoid Arthritis—The Search for New Diagnostic Glycomarkers
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252313060 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Ewa Maria Kratz und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Laboratory Diagnostics, Department of Laboratory Diagnostics, Faculty of Pharmacy, Wroclaw Medical University, Borowska Street 211A, 50-5…. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Clusterin, Arthritis, Psoriatic, Biomarkers. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This research was financed through a subsidy by the Polish Ministry of Health, Polish Ministry of Health.
Abstract (Originalsprache)
Psoriatic arthritis (PsA) and rheumatoid arthritis (RA) are connective tissue autoimmune diseases. The present study aimed to check whether serum clusterin (CLU) concentration and its glycosylation pattern may be markers differentiating these diseases—blood sera of patients with PsA (n = 37), RA (n = 34), and healthy subjects (control, n = 21) were examined. CLU concentration was measured using the ELISA test. Glycosylation was analyzed using lectin-ELISA with sialo-specific lectins from Maackia amurensis (MAA) and Sambucus nigra (SNA) recognizing sialic acid (SA) α2,3- and α2,6-linked, respectively, and fucose-specific lectins from Lotus tetragonolobus (LTA), Ulex europaeus (UEA), and Lens culinaris (LCA) specific to fucose α1,3-linked, α1,2-linked, and core fucose, respectively. Significantly higher CLU concentrations were observed in the PsA than in the RA patients. The expression of α2,6-linked SA was significantly higher in the PsA and RA patients than in the control. The expression of SNA-reactive SA was visibly higher in the PsA compared to the RA and control group but insignificant. Negative significant correlations between CLU concentrations and its glycans reactivity with LTA and UEA were also observed. Significantly higher serum CLU concentration, accompanied by a high expression of SNA-reactive SA and a reduced degree of Lewisx and Lewisy antennary fucosylation, may constitute a promising panel of parameters differentiating PsA from RA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Laboratory Diagnostics, Department of Laboratory Diagnostics, Faculty of Pharmacy, Wroclaw Medical University, Borowska Street 211A, 50-556 Wroclaw, Poland.
- Department of Toxicology, Faculty of Pharmacy, Wroclaw Medical University, Borowska Street 211, 50-556 Wroclaw, Poland.
- Department of Rheumatology and Internal Medicine, Wroclaw Medical University, Borowska Street 213, 50-556 Wroclaw, Poland.
ORCID-Profile: Ewa Maria Kratz, Izabela Kokot, Bogusława Konopska, Renata Sokolik
Förderung
- This research was financed through a subsidy by the Polish Ministry of Health
- Polish Ministry of Health
Zitieren
APA
Kratz, E. M., Kacperczyk, M., Kokot, I., Piwowar, A., Konopska, B., Sokolik, R., & Korman, L. (2024). Glycosylation Pattern of Serum Clusterin in Psoriatic Arthritis and Rheumatoid Arthritis—The Search for New Diagnostic Glycomarkers. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252313060
Vancouver
Kratz EM, Kacperczyk M, Kokot I, Piwowar A, Konopska B, Sokolik R, et al. Glycosylation Pattern of Serum Clusterin in Psoriatic Arthritis and Rheumatoid Arthritis—The Search for New Diagnostic Glycomarkers. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252313060
BibTeX
@article{Kratz2024,
author = {Kratz, Ewa Maria and Kacperczyk, Monika and Kokot, Izabela and Piwowar, Agnieszka and Konopska, Bogusława and Sokolik, Renata and Korman, Lucyna},
title = {Glycosylation Pattern of Serum Clusterin in Psoriatic Arthritis and Rheumatoid Arthritis—The Search for New Diagnostic Glycomarkers},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252313060}
}
EUVIMED